NM_001034853.2:c.223A>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001034853.2(RPGR):​c.223A>G​(p.Ile75Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0139 in 1,208,675 control chromosomes in the GnomAD database, including 224 homozygotes. There are 5,304 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★★).

Frequency

Genomes: 𝑓 0.032 ( 85 hom., 1018 hem., cov: 23)
Exomes 𝑓: 0.012 ( 139 hom. 4286 hem. )

Consequence

RPGR
NM_001034853.2 missense

Scores

16

Clinical Significance

Benign reviewed by expert panel B:11O:1

Conservation

PhyloP100: 0.0920

Publications

6 publications found
Variant links:
Genes affected
RPGR (HGNC:10295): (retinitis pigmentosa GTPase regulator) This gene encodes a protein with a series of six RCC1-like domains (RLDs), characteristic of the highly conserved guanine nucleotide exchange factors. The encoded protein is found in the Golgi body and interacts with RPGRIP1. This protein localizes to the outer segment of rod photoreceptors and is essential for their viability. Mutations in this gene have been associated with X-linked retinitis pigmentosa (XLRP). Multiple alternatively spliced transcript variants that encode different isoforms of this gene have been reported, but the full-length natures of only some have been determined. [provided by RefSeq, Dec 2008]
RPGR Gene-Disease associations (from GenCC):
  • retinitis pigmentosa 3
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • RPGR-related retinopathy
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • primary ciliary dyskinesia-retinitis pigmentosa syndrome
    Inheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • cone-rod dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • retinitis pigmentosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • macular degeneration, X-linked atrophic
    Inheritance: XL Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0020298362).
BP6
Variant X-38322877-T-C is Benign according to our data. Variant chrX-38322877-T-C is described in ClinVar as Benign. ClinVar VariationId is 100560.Status of the report is reviewed_by_expert_panel, 3 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0856 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RPGRNM_001034853.2 linkc.223A>G p.Ile75Val missense_variant Exon 3 of 15 ENST00000645032.1 NP_001030025.1 Q92834-6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RPGRENST00000645032.1 linkc.223A>G p.Ile75Val missense_variant Exon 3 of 15 NM_001034853.2 ENSP00000495537.1 Q92834-6
ENSG00000250349ENST00000465127.1 linkc.172-343244T>C intron_variant Intron 3 of 8 5 ENSP00000417050.1 B4E171

Frequencies

GnomAD3 genomes
AF:
0.0315
AC:
3538
AN:
112158
Hom.:
84
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0882
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0165
Gnomad ASJ
AF:
0.0196
Gnomad EAS
AF:
0.00444
Gnomad SAS
AF:
0.0112
Gnomad FIN
AF:
0.00148
Gnomad MID
AF:
0.0385
Gnomad NFE
AF:
0.00930
Gnomad OTH
AF:
0.0217
GnomAD2 exomes
AF:
0.0159
AC:
2909
AN:
183460
AF XY:
0.0147
show subpopulations
Gnomad AFR exome
AF:
0.0958
Gnomad AMR exome
AF:
0.00769
Gnomad ASJ exome
AF:
0.0210
Gnomad EAS exome
AF:
0.00649
Gnomad FIN exome
AF:
0.00175
Gnomad NFE exome
AF:
0.00955
Gnomad OTH exome
AF:
0.0135
GnomAD4 exome
AF:
0.0121
AC:
13283
AN:
1096466
Hom.:
139
Cov.:
28
AF XY:
0.0118
AC XY:
4286
AN XY:
362086
show subpopulations
African (AFR)
AF:
0.0903
AC:
2379
AN:
26357
American (AMR)
AF:
0.00861
AC:
303
AN:
35205
Ashkenazi Jewish (ASJ)
AF:
0.0193
AC:
373
AN:
19356
East Asian (EAS)
AF:
0.00252
AC:
76
AN:
30129
South Asian (SAS)
AF:
0.0140
AC:
757
AN:
54108
European-Finnish (FIN)
AF:
0.00222
AC:
90
AN:
40525
Middle Eastern (MID)
AF:
0.0281
AC:
116
AN:
4128
European-Non Finnish (NFE)
AF:
0.0101
AC:
8503
AN:
840627
Other (OTH)
AF:
0.0149
AC:
686
AN:
46031
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
413
825
1238
1650
2063
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
388
776
1164
1552
1940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0316
AC:
3548
AN:
112209
Hom.:
85
Cov.:
23
AF XY:
0.0296
AC XY:
1018
AN XY:
34373
show subpopulations
African (AFR)
AF:
0.0884
AC:
2729
AN:
30880
American (AMR)
AF:
0.0164
AC:
174
AN:
10578
Ashkenazi Jewish (ASJ)
AF:
0.0196
AC:
52
AN:
2653
East Asian (EAS)
AF:
0.00445
AC:
16
AN:
3593
South Asian (SAS)
AF:
0.0109
AC:
30
AN:
2750
European-Finnish (FIN)
AF:
0.00148
AC:
9
AN:
6078
Middle Eastern (MID)
AF:
0.0425
AC:
9
AN:
212
European-Non Finnish (NFE)
AF:
0.00930
AC:
495
AN:
53242
Other (OTH)
AF:
0.0221
AC:
34
AN:
1539
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
125
251
376
502
627
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0126
Hom.:
542
Bravo
AF:
0.0357
TwinsUK
AF:
0.00863
AC:
32
ALSPAC
AF:
0.00692
AC:
20
ESP6500AA
AF:
0.0895
AC:
343
ESP6500EA
AF:
0.00907
AC:
61
ExAC
AF:
0.0168
AC:
2044
EpiCase
AF:
0.0106
EpiControl
AF:
0.0112

ClinVar

Significance: Benign
Submissions summary: Benign:11Other:1
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

not provided Benign:4Other:1
-
NEI Ophthalmic Genomics Laboratory, National Institutes of Health
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

Nov 27, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Department of Ophthalmology and Visual Sciences Kyoto University
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 22995991, 22025579, 9399904, 27884173) -

not specified Benign:3
Jan 11, 2022
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 13, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Ile75Val in exon 3 of RPGR: This variant is not expected to have clinical sign ificance because it has been identified in 8.9% (343/3833) of African American c hromosomes from a broad population by the NHLBI Exome Sequencing Project (http:/ /evs.gs.washington.edu/EVS; dbSNP rs111631988). -

Primary ciliary dyskinesia Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 01, 2014
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

X-linked cone-rod dystrophy 1;C1845667:Retinitis pigmentosa 3;C2749137:Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness;C3151784:Macular degeneration, X-linked atrophic Benign:1
Nov 09, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

RPGR-related retinopathy Benign:1
Aug 04, 2025
ClinGen X-linked Inherited Retinal Disease Variant Curation Expert Panel, ClinGen
Significance:Benign
Review Status:reviewed by expert panel
Collection Method:curation

NM_001034853.2(RPGR):c.223A>G (p.Ile75Val) is a missense variant predicted to cause substitution of isoleucine by valine at amino acid 75. This variant is present in gnomAD v.4.1.0 at a frequency of 0.01338 among hemizygous individuals, with 5304 variant alleles / 396,459 total hemizygous alleles, which is higher than the ClinGen X-linked IRD VCEP BA1 threshold of >0.000005 (BA1). The computational predictor REVEL gives a score of 0.218, which is below the ClinGen X-linked IRD VCEP threshold of <0.290 and predicts a non-damaging effect on RPGR function. However, the splicing impact predictor SpliceAI gives a delta score of 0.12 for acceptor gain, which falls in the intermediate range above the ClinGen X-linked IRD VCEP recommended BP4 threshold of <0.1 but lower than the PP3 threshold of >0.2, so neither in silico code is met. In summary, this variant is classified as benign for RPGR-related retinopathy based on the ClinGen X-linked Inherited Retinal Disease Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for RPGR Version 1.0.0; BA1. (date of approval 05/16/2025). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.051
BayesDel_addAF
Benign
-0.75
T
BayesDel_noAF
Benign
-0.77
CADD
Benign
0.0090
DANN
Benign
0.62
DEOGEN2
Benign
0.11
.;.;T;.;.;.;.;.
FATHMM_MKL
Benign
0.0049
N
LIST_S2
Benign
0.35
.;T;T;T;T;.;T;T
MetaRNN
Benign
0.0020
T;T;T;T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-0.93
N;N;N;.;N;N;N;.
PhyloP100
0.092
PrimateAI
Benign
0.26
T
PROVEAN
Benign
0.51
N;.;N;.;.;.;N;.
REVEL
Benign
0.22
Sift
Benign
1.0
T;.;T;.;.;.;.;.
Sift4G
Benign
1.0
T;.;T;.;.;.;T;.
Polyphen
0.0
B;B;.;.;.;.;.;.
Vest4
0.048
MPC
0.60
ClinPred
0.0064
T
GERP RS
-1.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.066
gMVP
0.78
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs111631988; hg19: chrX-38182130; API